Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
1999-02-12
2002-05-21
Kemmerer, Elizabeth (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S350000, C530S324000, C530S326000, C514S002600, C424S085100
Reexamination Certificate
active
06392018
ABSTRACT:
2. FIELD OF THE INVENTION
The present invention provides novel polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic and research utilities for these polynucleotides and proteins.
3. BACKGROUND
Technology aimed at the discovery of protein factors (including e.g., cytokines, such as lymphokines, interferons, CSFs and interleukins) has matured rapidly over the past decade. The now routine hybridization cloning and expression cloning techniques clone novel polynucleotides “directly” in the sense that they rely on information directly related to the discovered protein (i.e., partial DNA/amino acid sequence of the protein in the case of hybridization cloning; activity of the protein in the case of expression cloning). More recent “indirect” cloning techniques such as signal sequence cloning, which isolates DNA sequences based on the presence of a now well-recognized secretory leader sequence motif, as well as various PCR-based or low stringency hybridization cloning techniques, have advanced the state of the art by making available large numbers of DNA/amino acid sequences for proteins that are known to have biological activity by virtue of their secreted nature in the case of leader sequence cloning, or by virtue of the cell or tissue source in the case of PCR-based techniques. It is to these proteins and the polynucleotides encoding them that the present invention is directed.
4. SUMMARY OF THE INVENTION
The compositions of the present invention include novel isolated polypeptides, in particular, novel EGF-repeat-containing polypeptides, isolated polynucleotides encoding such polypeptides, including recombinant DNA molecules, cloned genes or degenerate variants thereof, especially naturally occurring variants such as allelic variants, and antibodies that specifically recognize one or more epitopes present on such polypeptides.
The compositions of the present invention additionally include vectors, including expression vectors, containing the polynucleotides of the invention, cells genetically engineered to contain such polynucleotides and cells genetically engineered to express such polynucleotides.
The isolated polynucleotides of the invention include, but are not limited to, a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NOS: 3, or 6; a polynucleotide encoding a polypeptide comprising amino acid residues 1-502 of SEQ ID: 4 (The first amino acid residue in the sequence is designated as 1); a polynucleotide encoding a polypeptide comprising amino acid residues 1-21 of SEQ ID NO: 6; a polynucleotide encoding a polypeptide comprising amino acid residues 80-93 of SEQ ID NO: 6; a polynucleotide encoding a polypeptide comprising amino acid residues 95-128 of SEQ ID NO: 6; a polynucleotide encoding a polypeptide comprising amino acid residues 133-168 of SEQ ID NO: 6; a polynucleotide encoding a polypeptide comprising amino acid residues 175-214 of SEQ ID NO: 6; a polynucleotide encoding a polypeptide comprising amino acid residues 220-259 of SEQ ID NO: 6; a polynucleotide encoding a polypeptide comprising amino acid residues 446-465 of SEQ ID NO: 6; or a polynucleotide encoding a polypeptide comprising amino acid residues 363-365 of SEQ ID NO: 6.
The isolated polynucleotides of the invention further include, but are not limited to, a polynucleotide comprising the nucleotide sequence of SEQ ID NOS: 1, 2 or 5; a polynucleotide comprising nucleotides 205-267 of the nucleotide sequence of SEQ ID NO: 5 (The first nucleic acid residue of the sequence is designated as 1); a polynucleotide comprising nucleotides 442-483 of the nucleotide sequence of SEQ ID NO: 5; a polynucleotide comprising nucleotides 487-588 of the nucleotide sequence of SEQ ID NO: 5; a polynucleotide comprising nucleotides 601-708 of the nucleotide sequence of SEQ ID NO: 5; a polynucleotide comprising nucleotides 727-846 of the nucleotide sequence of SEQ ID NO: 5; a polynucleotide comprising nucleotides 862-981 of the nucleotide sequence of SEQ ID NO: 5; a polynucleotide comprising nucleotides 1540-1599 of the nucleotide sequence of SEQ ID NO: 5; a polynucleotide comprising nucleotides 1729-1731 of the nucleotide sequence of SEQ ID NO: 5; or a polynucleotide comprising nucleotides 1291-1299 of the nucleotide sequence of SEQ ID NO: 5.
The polynucleotides of the present invention still further include, but are not limited to, a polynucleotide comprising the nucleotide sequence of a cDNA insert of clone pEGFR-HY1 deposited with the American Type Culture Collection (ATCC; 10801 University Blvd., Manassas, Va., 20110-2209, U.S.A.); a polynucleotide comprising a nucleotide sequence of the cDNA insert of clone pEGFR-HY2 deposited with the ATCC; a polynucleotide comprising a nucleotide sequence of the cDNA insert of clone pEGFR-HY3 deposited with the ATCC; a polynucleotide comprising a nucleotide sequence encoding a polypeptide comprising the amino acid sequence encoded by the cDNA insert of clone pEGFR-HY1; a polynucleotide comprising a nucleotide sequence encoding a polypeptide comprising the amino acid sequence encoded by the cDNA insert of clone pEGFR-HY2; a polynucleotide comprising the nucleotide sequence encoding a polypeptide comprising the amino acid sequence encoded by the cDNA insert of clone pEGFR-HY3; a polynucleotide comprising the full length protein coding sequence of SEQ ID NO: 6 which polynucleotide comprises the cDNA insert of clone pEGFR-HY2, nucleic acids 323-357 of SEQ ID NO: 5 and the cDNA insert of clone pEGFR-HY1; a polynucleotide comprising the nucleotide sequence of the mature protein coding sequence of SEQ ID NO: 6 comprising the cDNA insert of clone pEGFR-HY2, nucleic acids 323-357 of SEQ ID NO: 5 and the cDNA insert of clone pEGFR-HY1; a polynucleotide comprising the full length protein coding sequence of SEQ ID NO: 6 which polynucleotide is assembled from the cDNA insert of clone pEGFR-HY2, the cDNA insert of pEGFR-HY3 and the cDNA insert of clone pEGFR-HY1; or a polynucleotide comprising the nucleotide sequence of the mature protein coding sequence of SEQ ID NO: 6 which polynucleotide is assembled from the cDNA insert of clone pEGFR-HY2, the cDNA insert of clone pEGFR-HY3 and the cDNA insert of clone pEGFR-HY1. The polynucleotides of the present invention also include, but are not limited to, a polynucleotide that hybridizes to the complement of the nucleotide sequence of SEQ ID NOS: 1, 2 or 5 under stringent hybridization conditions; a polynucleotide which is an allelic variant of any polynucleotide recited above; a polynucleotide which encodes a species homologue of any of the proteins recited above; or a polynucleotide that encodes a polypeptide comprising a specific domain or truncation of the polypeptide of SEQ ID NO: 3 or 6 or amino acids 1-502 of SEQ ID NO: 4.
The polynucleotides of the invention additionally include the complement of any of the polynucleotides recited above.
The isolated polypeptides of the invention include, but are not limited to, a polypeptide comprising the amino acid sequence of SEQ ID NOS: 3or 6; a polypeptide comprising amino acid residues 1-502 of SEQ ID NO: 4; a polypeptide comprising amino acid residues 1-21 of SEQ ID NO: 6; a polypeptide comprising amino acid residues 80-93 of SEQ ID NO: 6; a polypeptide comprising amino acid residues 95-128 of SEQ ID NO: 6; a polypeptide comprising amino acid residues 133-168 of SEQ ID NO: 6; a polypeptide comprising amino acid residues 175-214 of SEQ ID NO: 6; a polypeptide comprising amino acid residues 220-259 of SEQ ID NO: 6; a polypeptide comprising amino acid residues 446-465 of SEQ ID NO: 6; or a polypeptide comprising amino acid residues 363-365 of SEQ ID NO: 6.
The polypeptides of the present invention further include, but are not limited to, a polypeptide comprising the amino acid sequence encoded by the cDNA insert of clone pEGFR-HY1 deposited with the ATCC; a polypeptide comprising the amino acid encoded by the cDNA insert of clone pEGFR-HY2 deposited with the ATCC; a polypeptide comprising the amino acid encoded by the cDNA insert of clo
Ford John
Yeung George
Hyseq Inc.
Kemmerer Elizabeth
Marshall Gerstein & Borun
Wegert Sandra
LandOfFree
EGF MOTIF protein obtained from a cDNA library of fetal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with EGF MOTIF protein obtained from a cDNA library of fetal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and EGF MOTIF protein obtained from a cDNA library of fetal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2879340